Collaborative Stage Data Set - Revised 06/30/2008 FINAL
| Code | Description |
| 8000/0 | Neoplasm, benign |
| 8000/1 | Neoplasm, uncertain whether benign or malignant |
| 8000/3 | Neoplasm, malignant |
| 8000/6 | Neoplasm, metastatic |
| 8000/9 | Neoplasm, malignant, uncertain whether primary or metastatic |
| 8001/0 | Tumor cells, benign |
| 8001/1 | Tumor cells, uncertain whether benign or malignant |
| 8001/3 | Tumor cells, malignant |
| 8002/3 | Malignant tumor, small cell type |
| 8003/3 | Malignant tumor, giant cell type |
| 8004/3 | Malignant tumor, spindle cell type |
| 8005/0 | Clear cell tumor, NOS |
| 8005/3 | Malignant tumor, clear cell type |
| 8010/0 | Epithelial tumor, benign |
| 8010/2 | Carcinoma in situ, NOS |
| 8010/3 | Carcinoma, NOS |
| 8010/6 | Carcinoma, metastatic, NOS |
| 8010/9 | Carcinomatosis |
| 8011/0 | Epithelioma, benign |
| 8011/3 | Epithelioma, malignant |
| 8012/3 | Large cell carcinoma, NOS |
| 8013/3 | Large cell neuroendocrine carcinoma |
| 8014/3 | Large cell carcinoma with rhabdoid phenotype |
| 8015/3 | Glassy cell carcinoma |
| 8020/3 | Carcinoma, undifferentiated, NOS |
| 8021/3 | Carcinoma, anaplastic, NOS |
| 8022/3 | Pleomorphic carcinoma |
| 8030/3 | Giant cell and spindle cell carcinoma |
| 8031/3 | Giant cell carcinoma |
| 8032/3 | Spindle cell carcinoma, NOS |
| 8033/3 | Pseudosarcomatous carcinoma |
| 8034/3 | Polygonal cell carcinoma |
| 8035/3 | Carcinoma with osteoclast-like giant cells |
| 8040/0 | Tumorlet, benign |
| 8040/1 | Tumorlet, NOS |
| 8041/3 | Small cell carcinoma, NOS |
| 8042/3 | Oat cell carcinoma (C34._) |
| 8043/3 | Small cell carcinoma, fusiform cell |
| 8044/3 | Small cell carcinoma, intermediate cell |
| 8045/3 | Combined small cell carcinoma |
| 8046/3 | Non-small cell carcinoma (C34._) |
| 8050/0 | Papilloma, NOS (except papilloma of bladder M-8120/1) |
| 8050/2 | Papillary carcinoma in situ |
| 8050/3 | Papillary carcinoma, NOS |
| 8051/0 | Verrucous papilloma |
| 8051/3 | Verrucous carcinoma, NOS |
| 8052/0 | Squamous cell papilloma, NOS |
| 8052/2 | Papillary squamous cell carcinoma, non-invasive |
| 8052/3 | Papillary squamous cell carcinoma |
| 8053/0 | Squamous cell papilloma, inverted |
| 8060/0 | Squamous papillomatosis |
| 8070/2 | Squamous cell carcinoma in situ, NOS |
| 8070/3 | Squamous cell carcinoma, NOS |
| 8070/6 | Squamous cell carcinoma, metastatic, NOS |
| 8071/3 | Squamous cell carcinoma, keratinizing, NOS |
| 8072/3 | Squamous cell carcinoma, large cell, nonkeratinizing, NOS |
| 8073/3 | Squamous cell carcinoma, small cell, nonkeratinizing |
| 8074/3 | Squamous cell carcinoma, spindle cell |
| 8075/3 | Squamous cell carcinoma, adenoid |
| 8076/2 | Squamous cell carcinoma in situ with questionable stromal invasion |
| 8076/3 | Squamous cell carcinoma, microinvasive |
| 8077/2 | Squamous intraepithelial neoplasia, grade III |
| 8078/3 | Squamous cell carcinoma with horn formation |
| 8080/2 | Queyrat erythroplasia (C60._) |
| 8081/2 | Bowen disease (C44._) |
| 8082/3 | Lymphoepithelial carcinoma |
| 8083/3 | Basaloid squamous cell carcinoma |
| 8084/3 | Squamous cell carcinoma, clear cell type |
| 8090/1 | Basal cell tumor (C44._) |
| 8090/3 | Basal cell carcinoma, NOS (C44._) |
| 8091/3 | Multifocal superficial basal cell carcinoma (C44._) |
| 8092/3 | Infiltrating basal cell carcinoma, NOS (C44._) |
| 8093/3 | Basal cell carcinoma, fibroepithelial (C44._) |
| 8094/3 | Basosquamous carcinoma (C44._) |
| 8095/3 | Metatypical carcinoma (C44._) |
| 8096/0 | Intraepidermal epithelioma of Jadassohn (C44._) |
| 8097/3 | Basal cell carcinoma, nodular (C44._) |
| 8098/3 | Adenoid basal carcinoma (C53._) |
| 8100/0 | Trichoepithelioma (C44._) |
| 8101/0 | Trichofolliculoma (C44._) |
| 8102/0 | Trichilemmoma (C44._) |
| 8102/3 | Trichilemmocarcinoma (C44._) |
| 8103/0 | Pilar tumor (C44._) |
| 8110/0 | Pilomatrixoma, NOS (C44._) |
| 8110/3 | Pilomatrix carcinoma (C44._) |
| 8120/0 | Transitional cell papilloma, benign |
| 8120/1 | Urothelial papilloma, NOS |
| 8120/2 | Transitional cell carcinoma in situ |
| 8120/3 | Transitional cell carcinoma, NOS |
| 8121/0 | Schneiderian papilloma, NOS (C30.0, C31._) |
| 8121/1 | Transitional cell papilloma, inverted, NOS |
| 8121/3 | Schneiderian carcinoma (C30.0, C31._) |
| 8122/3 | Transitional cell carcinoma, spindle cell |
| 8123/3 | Basaloid carcinoma |
| 8124/3 | Cloacogenic carcinoma (C21.2) |
| 8130/1 | Papillary transitional cell neoplasm of low malignant potential (C67._) |
| 8130/2 | Papillary transitional cell carcinoma, non-invasive (C67._) |
| 8130/3 | Papillary transitional cell carcinoma (C67._) |
| 8131/3 | Transitional cell carcinoma, micropapillary (C67._) |
| 8140/0 | Adenoma, NOS |
| 8140/1 | Atypical adenoma |
| 8140/2 | Adenocarcinoma in situ, NOS |
| 8140/3 | Adenocarcinoma, NOS |
| 8140/6 | Adenocarcinoma, metastatic, NOS |
| 8141/3 | Scirrhous adenocarcinoma |
| 8142/3 | Linitis plastica (C16._) |
| 8143/3 | Superficial spreading adenocarcinoma |
| 8144/3 | Adenocarcinoma, intestinal type (C16._) |
| 8145/3 | Carcinoma, diffuse type (C16._) |
| 8146/0 | Monomorphic adenoma |
| 8147/0 | Basal cell adenoma |
| 8147/3 | Basal cell adenocarcinoma |
| 8148/2 | Glandular intraepithelial neoplasia, grade III |
| 8149/0 | Canalicular adenoma |
| 8150/0 | Islet cell adenoma (C25._) |
| 8150/1 | Islet cell tumor, NOS (C25._) |
| 8150/3 | Islet cell carcinoma (C25._) |
| 8151/0 | Insulinoma, NOS (C25._) |
| 8151/3 | Insulinoma, malignant (C25._) |
| 8152/1 | Glucagonoma, NOS (C25._) |
| 8152/3 | Glucagonoma, malignant (C25._) |
| 8153/1 | Gastrinoma, NOS |
| 8153/3 | Gastrinoma, malignant |
| 8154/3 | Mixed islet cell and exocrine adenocarcinoma (C25._) |
| 8155/1 | Vipoma, NOS |
| 8155/3 | Vipoma, malignant |
| 8156/1 | Somatostatinoma, NOS |
| 8156/3 | Somatostatinoma, malignant |
| 8157/1 | Enteroglucagonoma, NOS |
| 8157/3 | Enteroglucagonoma, malignant |
| 8160/0 | Bile duct adenoma (C22.1, C24.0) |
| 8160/3 | Cholangiocarcinoma (C22.1, C24.0) |
| 8161/0 | Bile duct cystadenoma (C22.1, C24.0) |
| 8161/3 | Bile duct cystadenocarcinoma (C22.1, C24.0) |
| 8162/3 | Klatskin tumor (C22.1, C24.0) |
| 8170/0 | Liver cell adenoma (C22.0) |
| 8170/3 | Hepatocellular carcinoma, NOS (C22.0) |
| 8171/3 | Hepatocellular carcinoma, fibrolamellar (C22.0) |
| 8172/3 | Hepatocellular carcinoma, scirrhous (C22.0) |
| 8173/3 | Hepatocellular carcinoma, spindle cell variant (C22.0) |
| 8174/3 | Hepatocellular carcinoma, clear cell type (C22.0) |
| 8175/3 | Hepatocellular carcinoma, pleomorphic type (C22.0) |
| 8180/3 | Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0) |
| 8190/0 | Trabecular adenoma |
| 8190/3 | Trabecular adenocarcinoma |
| 8191/0 | Embryonal adenoma |
| 8200/0 | Eccrine dermal cylindroma (C44._) |
| 8200/3 | Adenoid cystic carcinoma |
| 8201/2 | Cribriform carcinoma in situ (C50._) |
| 8201/3 | Cribriform carcinoma, NOS |
| 8202/0 | Microcystic adenoma (C25._) |
| 8204/0 | Lactating adenoma (C50._) |
| 8210/0 | Adenomatous polyp, NOS |
| 8210/2 | Adenocarcinoma in situ in adenomatous polyp |
| 8210/3 | Adenocarcinoma in adenomatous polyp |
| 8211/0 | Tubular adenoma, NOS |
| 8211/3 | Tubular adenocarcinoma |
| 8212/0 | Flat adenoma |
| 8213/0 | Serrated adenoma (C18._) |
| 8214/3 | Parietal cell carcinoma (C16._) |
| 8215/3 | Adenocarcinoma of anal glands (C21.1) |
| 8220/0 | Adenomatous polyposis coli (C18._) |
| 8220/3 | Adenocarcinoma in adenomatous polyposis coli (C18._) |
| 8221/0 | Multiple adenomatous polyps |
| 8221/3 | Adenocarcinoma in multiple adenomatous polyps |
| 8230/2 | Ductal carcinoma in situ, solid type (C50._) |
| 8230/3 | Solid carcinoma, NOS |
| 8231/3 | Carcinoma simplex |
| 8240/1 | Carcinoid tumor of uncertain malignant potential |
| 8240/3 | Carcinoid tumor, NOS (except of appendix M-8240/1) |
| 8241/3 | Enterochromaffin cell carcinoid |
| 8242/1 | Enterochromaffin-like cell carcinoid, NOS |
| 8242/3 | Enterochromaffin-like cell tumor, malignant |
| 8243/3 | Goblet cell carcinoid |
| 8244/3 | Composite carcinoid |
| 8245/1 | Tubular carcinoid |
| 8245/3 | Adenocarcinoid tumor |
| 8246/3 | Neuroendocrine carcinoma, NOS |
| 8247/3 | Merkel cell carcinoma (C44._) |
| 8248/1 | Apudoma |
| 8249/3 | Atypical carcinoid tumor |
| 8250/1 | Pulmonary adenomatosis (C34._) |
| 8250/3 | Bronchiolo-alveolar adenocarcinoma, NOS (C34._) |
| 8251/0 | Alveolar adenoma (C34._) |
| 8251/3 | Alveolar adenocarcinoma (C34._) |
| 8252/3 | Bronchiolo-alveolar carcinoma, non-mucinous (C34._) |
| 8253/3 | Bronchiolo-alveolar carcinoma, mucinous (C34._) |
| 8254/3 | Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous (C34._) |
| 8255/3 | Adenocarcinoma with mixed subtypes |
| 8260/0 | Papillary adenoma, NOS |
| 8260/3 | Papillary adenocarcinoma, NOS |
| 8261/0 | Villous adenoma, NOS |
| 8261/2 | Adenocarcinoma in situ in villous adenoma |
| 8261/3 | Adenocarcinoma in villous adenoma |
| 8262/3 | Villous adenocarcinoma |
| 8263/0 | Tubulovillous adenoma, NOS |
| 8263/2 | Adenocarcinoma in situ in tubulovillous adenoma |
| 8263/3 | Adenocarcinoma in tubulovillous adenoma |
| 8264/0 | Papillomatosis, glandular |
| 8270/0 | Chromophobe adenoma (C75.1) |
| 8270/3 | Chromophobe carcinoma (C75.1) |
| 8271/0 | Prolactinoma (C75.1) |
| 8272/0 | Pituitary adenoma, NOS (C75.1) |
| 8272/3 | Pituitary carcinoma, NOS (C75.1) |
| 8280/0 | Acidophil adenoma (C75.1) |
| 8280/3 | Acidophil carcinoma (C75.1) |
| 8281/0 | Mixed acidophil-basophil adenoma (C75.1) |
| 8281/3 | Mixed acidophil-basophil carcinoma (C75.1) |
| 8290/0 | Oxyphilic adenoma |
| 8290/3 | Oxyphilic adenocarcinoma |
| 8300/0 | Basophil adenoma (C75.1) |
| 8300/3 | Basophil carcinoma (C75.1) |
| 8310/0 | Clear cell adenoma |
| 8310/3 | Clear cell adenocarcinoma, NOS |
| 8311/1 | Hypernephroid tumor [obs] |
| 8312/3 | Renal cell carcinoma, NOS (C64.9) |
| 8313/0 | Clear cell adenofibroma (C56.9) |
| 8313/1 | Clear cell adenofibroma of borderline malignancy (C56.9) |
| 8313/3 | Clear cell adenocarcinofibroma (C56.9) |
| 8314/3 | Lipid-rich carcinoma (C50._) |
| 8315/3 | Glycogen-rich carcinoma |
| 8316/3 | Cyst-associated renal cell carcinoma (C64.9) |
| 8317/3 | Renal cell carcinoma, chromophobe type (C64.9) |
| 8318/3 | Renal cell carcinoma, sarcomatoid (C64.9) |
| 8319/3 | Collecting duct carcinoma (C64.9) |
| 8320/3 | Granular cell carcinoma |
| 8321/0 | Chief cell adenoma (C75.0) |
| 8322/0 | Water-clear cell adenoma (C75.0) |
| 8322/3 | Water-clear cell adenocarcinoma (C75.0) |
| 8323/0 | Mixed cell adenoma |
| 8323/3 | Mixed cell adenocarcinoma |
| 8324/0 | Lipoadenoma |
| 8325/0 | Metanephric adenoma (C64.9) |
| 8330/0 | Follicular adenoma (C73.9) |
| 8330/1 | Atypical follicular adenoma (C73.9) |
| 8330/3 | Follicular adenocarcinoma, NOS (C73.9) |
| 8331/3 | Follicular adenocarcinoma, well differentiated (C73.9) |
| 8332/3 | Follicular adenocarcinoma, trabecular (C73.9) |
| 8333/0 | Microfollicular adenoma, NOS (C73.9) |
| 8333/3 | Fetal adenocarcinoma |
| 8334/0 | Macrofollicular adenoma (C73.9) |
| 8335/3 | Follicular carcinoma, minimally invasive (C73.9) |
| 8336/0 | Hyalinizing trabecular adenoma (C73.9) |
| 8337/3 | Insular carcinoma (C73.9) |
| 8340/3 | Papillary carcinoma, follicular variant (C73.9) |
| 8341/3 | Papillary microcarcinoma (C73.9) |
| 8342/3 | Papillary carcinoma, oxyphilic cell (C73.9) |
| 8343/3 | Papillary carcinoma, encapsulated (C73.9) |
| 8344/3 | Papillary carcinoma, columnar cell (C73.9) |
| 8345/3 | Medullary carcinoma with amyloid stroma (C73.9) |
| 8346/3 | Mixed medullary-follicular carcinoma (C73.9) |
| 8347/3 | Mixed medullary-papillary carcinoma (C73.9) |
| 8350/3 | Nonencapsulated sclerosing carcinoma (C73.9) |
| 8360/1 | Multiple endocrine adenomas |
| 8361/0 | Juxtaglomerular tumor (C64.9) |
| 8370/0 | Adrenal cortical adenoma, NOS (C74.0) |
| 8370/3 | Adrenal cortical carcinoma (C74.0) |
| 8371/0 | Adrenal cortical adenoma, compact cell (C74.0) |
| 8372/0 | Adrenal cortical adenoma, pigmented (C74.0) |
| 8373/0 | Adrenal cortical adenoma, clear cell (C74.0) |
| 8374/0 | Adrenal cortical adenoma, glomerulosa cell (C74.0) |
| 8375/0 | Adrenal cortical adenoma, mixed cell (C74.0) |
| 8380/0 | Endometrioid adenoma, NOS |
| 8380/1 | Endometrioid adenoma, borderline malignancy |
| 8380/3 | Endometrioid adenocarcinoma, NOS |
| 8381/0 | Endometrioid adenofibroma, NOS |
| 8381/1 | Endometrioid adenofibroma, borderline malignancy |
| 8381/3 | Endometrioid adenofibroma, malignant |
| 8382/3 | Endometrioid adenocarcinoma, secretory variant |
| 8383/3 | Endometrioid adenocarcinoma, ciliated cell variant |
| 8384/3 | Adenocarcinoma, endocervical type |
| 8390/0 | Skin appendage adenoma (C44._) |
| 8390/3 | Skin appendage carcinoma (C44._) |
| 8391/0 | Follicular fibroma (C44._) |
| 8392/0 | Syringofibroadenoma (C44._) |
| 8400/0 | Sweat gland adenoma (C44._) |
| 8400/1 | Sweat gland tumor, NOS (C44._) |
| 8400/3 | Sweat gland adenocarcinoma (C44._) |
| 8401/0 | Apocrine adenoma |
| 8401/3 | Apocrine adenocarcinoma |
| 8402/0 | Nodular hidradenoma (C44._) |
| 8402/3 | Nodular hidradenoma, malignant (C44._) |
| 8403/0 | Eccrine spiradenoma (C44._) |
| 8403/3 | Malignant eccrine spiradenoma (C44._) |
| 8404/0 | Hidrocystoma (C44._) |
| 8405/0 | Papillary hidradenoma |
| 8406/0 | Papillary syringadenoma (C44._) |
| 8407/0 | Syringoma, NOS (C44._) |
| 8407/3 | Sclerosing sweat duct carcinoma (C44._) |
| 8408/0 | Eccrine papillary adenoma (C44._) |
| 8408/1 | Aggressive digital papillary adenoma (C44._) |
| 8408/3 | Eccrine papillary adenocarcinoma (C44._) |
| 8409/0 | Eccrine poroma (C44._) |
| 8409/3 | Eccrine poroma, malignant |
| 8410/0 | Sebaceous adenoma (C44._) |
| 8410/3 | Sebaceous adenocarcinoma (C44._) |
| 8413/3 | Eccrine adenocarcinoma (C44._) |
| 8420/0 | Ceruminous adenoma (C44.2) |
| 8420/3 | Ceruminous adenocarcinoma (C44.2) |
| 8430/1 | Mucoepidermoid tumor [obs] |
| 8430/3 | Mucoepidermoid carcinoma |
| 8440/0 | Cystadenoma, NOS |
| 8440/3 | Cystadenocarcinoma, NOS |
| 8441/0 | Serous cystadenoma, NOS |
| 8441/3 | Serous cystadenocarcinoma, NOS (C56.9) |
| 8442/1 | Serous cystadenoma, borderline malignancy (C56.9) |
| 8443/0 | Clear cell cystadenoma (C56.9) |
| 8444/1 | Clear cell cystic tumor of borderline malignancy (C56.9) |
| 8450/0 | Papillary cystadenoma, NOS (C56.9) |
| 8450/3 | Papillary cystadenocarcinoma, NOS (C56.9) |
| 8451/1 | Papillary cystadenoma, borderline malignancy (C56.9) |
| 8452/1 | Solid pseudopapillary tumor (C25._) |
| 8452/3 | Solid pseudopapillary carcinoma (C25._) |
| 8453/0 | Intraductal papillary-mucinous adenoma (C25._) |
| 8453/1 | Intraductal papillary-mucinous tumor with moderate dysplasia (C25._) |
| 8453/2 | Intraductal papillary-mucinous carcinoma, non-invasive (C25._) |
| 8453/3 | Intraductal papillary-mucinous carcinoma, invasive (C25._) |
| 8454/0 | Cystic tumor of atrio-ventricular node (C38.0) |
| 8460/0 | Papillary serous cystadenoma, NOS (C56.9) |
| 8460/3 | Papillary serous cystadenocarcinoma (C56.9) |
| 8461/0 | Serous surface papilloma (C56.9) |
| 8461/3 | Serous surface papillary carcinoma (C56.9) |
| 8462/1 | Serous papillary cystic tumor of borderline malignancy (C56.9) |
| 8463/1 | Serous surface papillary tumor of borderline malignancy (C56.9) |
| 8470/0 | Mucinous cystadenoma, NOS (C56.9) |
| 8470/1 | Mucinous cystic tumor with moderate dysplasia (C25._) |
| 8470/2 | Mucinous cystadenocarcinoma, non-invasive (C25._) |
| 8470/3 | Mucinous cystadenocarcinoma, NOS (C56.9) |
| 8471/0 | Papillary mucinous cystadenoma, NOS (C56.9) |
| 8471/3 | Papillary mucinous cystadenocarcinoma (C56.9) |
| 8472/1 | Mucinous cystic tumor of borderline malignancy (C56.9) |
| 8473/1 | Papillary mucinous cystadenoma, borderline malignancy (C56.9) |
| 8480/0 | Mucinous adenoma |
| 8480/3 | Mucinous adenocarcinoma |
| 8480/6 | Pseudomyxoma peritonei |
| 8481/3 | Mucin-producing adenocarcinoma |
| 8482/3 | Mucinous adenocarcinoma, endocervical type |
| 8490/3 | Signet ring cell carcinoma |
| 8490/6 | Metastatic signet ring cell carcinoma |
| 8500/2 | Intraductal carcinoma, noninfiltrating, NOS |
| 8500/3 | Infiltrating duct carcinoma, NOS (C50._) |
| 8501/2 | Comedocarcinoma, noninfiltrating (C50._) |
| 8501/3 | Comedocarcinoma, NOS (C50._) |
| 8502/3 | Secretory carcinoma of breast (C50._) |
| 8503/0 | Intraductal papilloma |
| 8503/2 | Noninfiltrating intraductal papillary adenocarcinoma (C50._) |
| 8503/3 | Intraductal papillary adenocarcinoma with invasion (C50._) |
| 8504/0 | Intracystic papillary adenoma |
| 8504/2 | Noninfiltrating intracystic carcinoma |
| 8504/3 | Intracystic carcinoma, NOS |
| 8505/0 | Intraductal papillomatosis, NOS |
| 8506/0 | Adenoma of nipple (C50.0) |
| 8507/2 | Intraductal micropapillary carcinoma (C50._) |
| 8508/3 | Cystic hypersecretory carcinoma (C50._) |
| 8510/3 | Medullary carcinoma, NOS |
| 8512/3 | Medullary carcinoma with lymphoid stroma |
| 8513/3 | Atypical medullary carcinoma (C50._) |
| 8514/3 | Duct carcinoma, desmoplastic type |
| 8520/2 | Lobular carcinoma in situ, NOS (C50._) |
| 8520/3 | Lobular carcinoma, NOS (C50._) |
| 8521/3 | Infiltrating ductular carcinoma (C50._) |
| 8522/2 | Intraductal carcinoma and lobular carcinoma in situ (C50._) |
| 8522/3 | Infiltrating duct and lobular carcinoma (C50._) |
| 8523/3 | Infiltrating duct mixed with other types of carcinoma (C50._) |
| 8524/3 | Infiltrating lobular mixed with other types of carcinoma (C50._) |
| 8525/3 | Polymorphous low grade adenocarcinoma |
| 8530/3 | Inflammatory carcinoma (C50._) |
| 8540/3 | Paget disease, mammary (C50._) |
| 8541/3 | Paget disease and infiltrating duct carcinoma of breast (C50._) |
| 8542/3 | Paget disease, extramammary (except Paget disease of bone) |
| 8543/3 | Paget disease and intraductal carcinoma of breast (C50._) |
| 8550/0 | Acinar cell adenoma |
| 8550/1 | Acinar cell tumor [obs] |
| 8550/3 | Acinar cell carcinoma |
| 8551/3 | Acinar cell cystadenocarcinoma |
| 8560/0 | Mixed squamous cell and glandular papilloma |
| 8560/3 | Adenosquamous carcinoma |
| 8561/0 | Adenolymphoma (C07._, C08._) |
| 8562/3 | Epithelial-myoepithelial carcinoma |
| 8570/3 | Adenocarcinoma with squamous metaplasia |
| 8571/3 | Adenocarcinoma with cartilaginous and osseous metaplasia |
| 8572/3 | Adenocarcinoma with spindle cell metaplasia |
| 8573/3 | Adenocarcinoma with apocrine metaplasia |
| 8574/3 | Adenocarcinoma with neuroendocrine differentiation |
| 8575/3 | Metaplastic carcinoma, NOS |
| 8576/3 | Hepatoid adenocarcinoma |
| 8580/0 | Thymoma, benign (C37.9) |
| 8580/1 | Thymoma, NOS (C37.9) |
| 8580/3 | Thymoma, malignant, NOS (C37.9) |
| 8581/1 | Thymoma, type A, NOS (C37.9) |
| 8581/3 | Thymoma, type A, malignant (C37.9) |
| 8582/1 | Thymoma, type AB, NOS (C37.9) |
| 8582/3 | Thymoma, type AB, malignant (C37.9) |
| 8583/1 | Thymoma, type B1, NOS (C37.9) |
| 8583/3 | Thymoma, type B1, malignant (C37.9) |
| 8584/1 | Thymoma, type B2, NOS (C37.9) |
| 8584/3 | Thymoma, type B2, malignant (C37.9) |
| 8585/1 | Thymoma, type B3, NOS (C37.9) |
| 8585/3 | Thymoma, type B3, malignant (C37.9) |
| 8586/3 | Thymic carcinoma, NOS (C37.9) |
| 8587/0 | Ectopic hamartomatous thymoma |
| 8588/3 | Spindle epithelial tumor with thymus-like element |
| 8589/3 | Carcinoma showing thymus-like element |
| 8590/1 | Sex cord-gonadal stromal tumor, NOS |
| 8591/1 | Sex cord-gonadal stromal tumor, incompletely differentiated |
| 8592/1 | Sex cord-gonadal stromal tumor, mixed forms |
| 8593/1 | Stromal tumor with minor sex cord elements (C56.9) |
| 8600/0 | Thecoma, NOS (C56.9) |
| 8600/3 | Thecoma, malignant (C56.9) |
| 8601/0 | Thecoma, luteinized (C56.9) |
| 8602/0 | Sclerosing stromal tumor (C56.9) |
| 8610/0 | Luteoma, NOS (C56.9) |
| 8620/1 | Granulosa cell tumor, adult type (C56.9) |
| 8620/3 | Granulosa cell tumor, malignant (C56.9) |
| 8621/1 | Granulosa cell-theca cell tumor (C56.9) |
| 8622/1 | Granulosa cell tumor, juvenile (C56.9) |
| 8623/1 | Sex cord tumor with annular tubules (C56.9) |
| 8630/0 | Androblastoma, benign |
| 8630/1 | Androblastoma, NOS |
| 8630/3 | Androblastoma, malignant |
| 8631/0 | Sertoli-Leydig cell tumor, well differentiated |
| 8631/1 | Sertoli-Leydig cell tumor of intermediate differentiation |
| 8631/3 | Sertoli-Leydig cell tumor, poorly differentiated |
| 8632/1 | Gynandroblastoma (C56.9) |
| 8633/1 | Sertoli-Leydig cell tumor, retiform |
| 8634/1 | Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements |
| 8634/3 | Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements |
| 8640/1 | Sertoli cell tumor, NOS |
| 8640/3 | Sertoli cell carcinoma (C62._) |
| 8641/0 | Sertoli cell tumor with lipid storage |
| 8642/1 | Large cell calcifying Sertoli cell tumor |
| 8650/0 | Leydig cell tumor, benign (C62._) |
| 8650/1 | Leydig cell tumor, NOS (C62._) |
| 8650/3 | Leydig cell tumor, malignant (C62._) |
| 8660/0 | Hilus cell tumor (C56.9) |
| 8670/0 | Lipid cell tumor of ovary (C56.9) |
| 8670/3 | Steroid cell tumor, malignant |
| 8671/0 | Adrenal rest tumor |
| 8680/0 | Paraganglioma, benign |
| 8680/1 | Paraganglioma, NOS |
| 8680/3 | Paraganglioma, malignant |
| 8681/1 | Sympathetic paraganglioma |
| 8682/1 | Parasympathetic paraganglioma |
| 8683/0 | Gangliocytic paraganglioma (C17.0) |
| 8690/1 | Glomus jugulare tumor, NOS (C75.5) |
| 8691/1 | Aortic body tumor (C75.5) |
| 8692/1 | Carotid body tumor (C75.4) |
| 8693/1 | Extra-adrenal paraganglioma, NOS |
| 8693/3 | Extra-adrenal paraganglioma, malignant |
| 8700/0 | Pheochromocytoma, NOS (C74.1) |
| 8700/3 | Pheochromocytoma, malignant (C74.1) |
| 8720/0 | Pigmented nevus, NOS (C44._) |
| 8720/2 | Melanoma in situ |
| 8720/3 | Malignant melanoma, NOS (except juvenile melanoma M-8770/0) |
| 8721/3 | Nodular melanoma (C44._) |
| 8722/0 | Balloon cell nevus (C44._) |
| 8722/3 | Balloon cell melanoma (C44._) |
| 8723/0 | Halo nevus (C44._) |
| 8723/3 | Malignant melanoma, regressing (C44._) |
| 8725/0 | Neuronevus (C44._) |
| 8726/0 | Magnocellular nevus (C69.4) |
| 8727/0 | Dysplastic nevus (C44._) |
| 8728/0 | Diffuse melanocytosis (C70.9) |
| 8728/1 | Meningeal melanocytoma (C70.9) |
| 8728/3 | Meningeal melanomatosis (C70.9) |
| 8730/0 | Nonpigmented nevus (C44._) |
| 8730/3 | Amelanotic melanoma (C44._) |
| 8740/0 | Junctional nevus, NOS (C44._) |
| 8740/3 | Malignant melanoma in junctional nevus (C44._) |
| 8741/2 | Precancerous melanosis, NOS (C44._) |
| 8741/3 | Malignant melanoma in precancerous melanosis (C44._) |
| 8742/2 | Lentigo maligna (C44._) |
| 8742/3 | Lentigo maligna melanoma (C44._) |
| 8743/3 | Superficial spreading melanoma (C44._) |
| 8744/3 | Acral lentiginous melanoma, malignant (C44._) |
| 8745/3 | Desmoplastic melanoma, malignant (C44._) |
| 8746/3 | Mucosal lentiginous melanoma |
| 8750/0 | Intradermal nevus (C44._) |
| 8760/0 | Compound nevus (C44._) |
| 8761/0 | Small congenital nevus (C44._) |
| 8761/1 | Giant pigmented nevus, NOS (C44._) |
| 8761/3 | Malignant melanoma in giant pigmented nevus (C44._) |
| 8762/1 | Proliferative dermal lesion in congenital nevus (C44._) |
| 8770/0 | Epithelioid and spindle cell nevus (C44._) |
| 8770/3 | Mixed epithelioid and spindle cell melanoma |
| 8771/0 | Epithelioid cell nevus (C44._) |
| 8771/3 | Epithelioid cell melanoma |
| 8772/0 | Spindle cell nevus, NOS (C44._) |
| 8772/3 | Spindle cell melanoma, NOS |
| 8773/3 | Spindle cell melanoma, type A (C69._) |
| 8774/3 | Spindle cell melanoma, type B (C69._) |
| 8780/0 | Blue nevus, NOS (C44._) |
| 8780/3 | Blue nevus, malignant (C44._) |
| 8790/0 | Cellular blue nevus (C44._) |
| 8930/0 | Endometrial stromal nodule (C54.1) |
| 8930/3 | Endometrial stromal sarcoma, NOS (C54.1) |
| 8931/3 | Endometrial stromal sarcoma, low grade (C54.1) |
| 8932/0 | Adenomyoma |
| 8933/3 | Adenosarcoma |
| 8934/3 | Carcinofibroma |
| 8935/0 | Stromal tumor, benign |
| 8935/1 | Stromal tumor, NOS |
| 8935/3 | Stromal sarcoma, NOS |
| 8940/0 | Pleomorphic adenoma |
| 8940/3 | Mixed tumor, malignant, NOS |
| 8941/3 | Carcinoma in pleomorphic adenoma (C07._, C08._) |
| 8950/3 | Mullerian mixed tumor (C54._) |
| 8951/3 | Mesodermal mixed tumor |
| 8959/0 | Benign cystic nephroma (C64.9) |
| 8959/1 | Cystic partially differentiated nephroblastoma (C64.9) |
| 8959/3 | Malignant cystic nephroma (C64.9) |
| 8960/1 | Mesoblastic nephroma |
| 8960/3 | Nephroblastoma, NOS (C64.9) |
| 8963/3 | Malignant rhabdoid tumor |
| 8964/3 | Clear cell sarcoma of kidney (C64.9) |
| 8965/0 | Nephrogenic adenofibroma (C64.9) |
| 8966/0 | Renomedullary interstitial cell tumor (C64.9) |
| 8967/0 | Ossifying renal tumor (C64.9) |
| 8970/3 | Hepatoblastoma (C22.0) |
| 8971/3 | Pancreatoblastoma (C25._) |
| 8972/3 | Pulmonary blastoma (C34._) |
| 8973/3 | Pleuropulmonary blastoma |
| 8974/1 | Sialoblastoma |
| 8980/3 | Carcinosarcoma, NOS |
| 8981/3 | Carcinosarcoma, embryonal |
| 8982/0 | Myoepithelioma |
| 8982/3 | Malignant myoepithelioma |
| 8983/0 | Adenomyoepithelioma (C50._) |
| 9000/0 | Brenner tumor, NOS (C56.9) |
| 9000/1 | Brenner tumor, borderline malignancy (C56.9) |
| 9000/3 | Brenner tumor, malignant (C56.9) |
| 9010/0 | Fibroadenoma, NOS (C50._) |
| 9011/0 | Intracanalicular fibroadenoma (C50._) |
| 9012/0 | Pericanalicular fibroadenoma (C50._) |
| 9013/0 | Adenofibroma, NOS |
| 9014/0 | Serous adenofibroma, NOS |
| 9014/1 | Serous adenofibroma of borderline malignancy |
| 9014/3 | Serous adenocarcinofibroma |
| 9015/0 | Mucinous adenofibroma, NOS |
| 9015/1 | Mucinous adenofibroma of borderline malignancy |
| 9015/3 | Mucinous adenocarcinofibroma |
| 9016/0 | Giant fibroadenoma (C50._) |
| 9020/0 | Phyllodes tumor, benign (C50._) |
| 9020/1 | Phyllodes tumor, borderline (C50._) |
| 9020/3 | Phyllodes tumor, malignant (C50._) |
| 9030/0 | Juvenile fibroadenoma (C50._) |
| 9050/0 | Mesothelioma, benign |
| 9050/3 | Mesothelioma, malignant |
| 9051/0 | Fibrous mesothelioma, benign |
| 9051/3 | Fibrous mesothelioma, malignant |
| 9052/0 | Epithelioid mesothelioma, benign |
| 9052/3 | Epithelioid mesothelioma, malignant |
| 9053/3 | Mesothelioma, biphasic, malignant |
| 9054/0 | Adenomatoid tumor, NOS |
| 9055/0 | Multicystic mesothelioma, benign |
| 9055/1 | Cystic mesothelioma, NOS (C48._) |
| 9060/3 | Dysgerminoma |
| 9061/3 | Seminoma, NOS (C62._) |
| 9062/3 | Seminoma, anaplastic (C62._) |
| 9063/3 | Spermatocytic seminoma (C62._) |
| 9064/2 | Intratubular malignant germ cells (C62._) |
| 9064/3 | Germinoma |
| 9065/3 | Germ cell tumor, nonseminomatous (C62._) |
| 9070/3 | Embryonal carcinoma, NOS |
| 9071/3 | Yolk sac tumor |
| 9072/3 | Polyembryoma |
| 9073/1 | Gonadoblastoma |
| 9080/0 | Teratoma, benign |
| 9080/1 | Teratoma, NOS |
| 9080/3 | Teratoma, malignant, NOS |
| 9081/3 | Teratocarcinoma |
| 9082/3 | Malignant teratoma, undifferentiated |
| 9083/3 | Malignant teratoma, intermediate |
| 9084/0 | Dermoid cyst, NOS |
| 9084/3 | Teratoma with malignant transformation |
| 9085/3 | Mixed germ cell tumor |
| 9090/0 | Struma ovarii, NOS (C56.9) |
| 9090/3 | Struma ovarii, malignant (C56.9) |
| 9091/1 | Strumal carcinoid (C56.9) |
| 9100/0 | Hydatidiform mole, NOS (C58.9) |
| 9100/1 | Invasive hydatidiform mole (C58.9) |
| 9100/3 | Choriocarcinoma, NOS |
| 9101/3 | Choriocarcinoma combined with other germ cell elements |
| 9102/3 | Malignant teratoma, trophoblastic |
| 9103/0 | Partial hydatidiform mole (C58.9) |
| 9104/1 | Placental site trophoblastic tumor (C58.9) |
| 9105/3 | Trophoblastic tumor, epithelioid |
| 9110/0 | Mesonephroma, benign |
| 9110/1 | Mesonephric tumor, NOS |
| 9110/3 | Mesonephroma, malignant |
| 9140/3 | Kaposi sarcoma |
| 9141/0 | Angiokeratoma |
| 9142/0 | Verrucous keratotic hemangioma |
| 9262/0 | Ossifying fibroma |
| 9270/0 | Odontogenic tumor, benign |
| 9270/1 | Odontogenic tumor, NOS |
| 9270/3 | Odontogenic tumor, malignant |
| 9271/0 | Ameloblastic fibrodentinoma |
| 9272/0 | Cementoma, NOS |
| 9273/0 | Cementoblastoma, benign |
| 9274/0 | Cementifying fibroma |
| 9275/0 | Gigantiform cementoma |
| 9280/0 | Odontoma, NOS |
| 9281/0 | Compound odontoma |
| 9282/0 | Complex odontoma |
| 9290/0 | Ameloblastic fibro-odontoma |
| 9290/3 | Ameloblastic odontosarcoma |
| 9300/0 | Adenomatoid odontogenic tumor |
| 9301/0 | Calcifying odontogenic cyst |
| 9302/0 | Odontogenic ghost cell tumor |
| 9310/0 | Ameloblastoma, NOS |
| 9310/3 | Ameloblastoma, malignant |
| 9311/0 | Odontoameloblastoma |
| 9312/0 | Squamous odontogenic tumor |
| 9320/0 | Odontogenic myxoma |
| 9321/0 | Central odontogenic fibroma |
| 9322/0 | Peripheral odontogenic fibroma |
| 9330/0 | Ameloblastic fibroma |
| 9330/3 | Ameloblastic fibrosarcoma |
| 9340/0 | Calcifying epithelial odontogenic tumor |
| 9341/1 | Clear cell odontogenic tumor |
| 9342/3 | Odontogenic carcinosarcoma |
| 9350/1 | Craniopharyngioma (C75.2) |
| 9351/1 | Craniopharyngioma, adamantinomatous (C75.2) |
| 9352/1 | Craniopharyngioma, papillary (C75.2) |
| 9360/1 | Pinealoma (C75.3) |
| 9361/1 | Pineocytoma (C75.3) |
| 9362/3 | Pineoblastoma (C75.3) |
| 9363/0 | Melanotic neuroectodermal tumor |
| 9364/3 | Peripheral neuroectodermal tumor |
| 9365/3 | Askin tumor |
| 9380/3 | Glioma, malignant (C71._) |
| 9381/3 | Gliomatosis cerebri (C71._) |
| 9382/3 | Mixed glioma (C71._) |
| 9383/1 | Subependymoma (C71._) |
| 9384/1 | Subependymal giant cell astrocytoma (C71._) |
| 9390/0 | Choroid plexus papilloma, NOS (C71.5) |
| 9390/1 | Atypical choroid plexus papilloma (C71.5) |
| 9390/3 | Choroid plexus carcinoma (C71.5) |
| 9391/3 | Ependymoma, NOS (C71._) |
| 9392/3 | Ependymoma, anaplastic (C71._) |
| 9393/3 | Papillary ependymoma (C71._) |
| 9394/1 | Myxopapillary ependymoma (C72.0) |
| 9400/3 | Astrocytoma, NOS (C71._) |
| 9401/3 | Astrocytoma, anaplastic (C71._) |
| 9410/3 | Protoplasmic astrocytoma (C71._) |
| 9411/3 | Gemistocytic astrocytoma (C71._) |
| 9412/1 | Desmoplastic infantile astrocytoma (C71._) |
| 9413/0 | Dysembryoplastic neuroepithelial tumor |
| 9420/3 | Fibrillary astrocytoma (C71._) |
| 9421/1 | Pilocytic astrocytoma (C71._) |
| 9423/3 | Polar spongioblastoma (C71._) |
| 9424/3 | Pleomorphic xanthoastrocytoma (C71._) |
| 9430/3 | Astroblastoma (C71._) |
| 9440/3 | Glioblastoma, NOS (C71._) |
| 9441/3 | Giant cell glioblastoma (C71._) |
| 9442/1 | Gliofibroma (C71._) |
| 9442/3 | Gliosarcoma (C71._) |
| 9444/1 | Chordoid glioma (C71._) |
| 9450/3 | Oligodendroglioma, NOS (C71._) |
| 9451/3 | Oligodendroglioma, anaplastic (C71._) |
| 9460/3 | Oligodendroblastoma (C71._) [obs] |
| 9470/3 | Medulloblastoma, NOS (C71.6) |
| 9471/3 | Desmoplastic nodular medulloblastoma (C71.6) |
| 9472/3 | Medullomyoblastoma (C71.6) |
| 9474/3 | Large cell medulloblastoma (C71.6) |
| 9480/3 | Cerebellar sarcoma, NOS (C71.6) [obs] |
| 9490/0 | Ganglioneuroma |
| 9490/3 | Ganglioneuroblastoma |
| 9491/0 | Ganglioneuromatosis |
| 9492/0 | Gangliocytoma |
| 9493/0 | Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6) |
| 9500/3 | Neuroblastoma, NOS |
| 9501/0 | Medulloepithelioma, benign (C69.4) |
| 9501/3 | Medulloepithelioma, NOS |
| 9502/0 | Teratoid medulloepithelioma, benign (C69.4) |
| 9502/3 | Teratoid medulloepithelioma |
| 9503/3 | Neuroepithelioma, NOS |
| 9504/3 | Spongioneuroblastoma |
| 9505/1 | Ganglioglioma, NOS |
| 9505/3 | Ganglioglioma, anaplastic |
| 9506/1 | Central neurocytoma |
| 9507/0 | Pacinian tumor |
| 9508/3 | Atypical teratoid/rhabdoid tumor (C71._) |
| 9510/0 | Retinocytoma (C69.2) |
| 9510/3 | Retinoblastoma, NOS (C69.2) |
| 9511/3 | Retinoblastoma, differentiated (C69.2) |
| 9512/3 | Retinoblastoma, undifferentiated (C69.2) |
| 9513/3 | Retinoblastoma, diffuse (C69.2) |
| 9514/1 | Retinoblastoma, spontaneously regressed (C69.2) |
| 9520/3 | Olfactory neurogenic tumor |
| 9521/3 | Olfactory neurocytoma (C30.0) |
| 9522/3 | Olfactory neuroblastoma (C30.0) |
| 9523/3 | Olfactory neuroepithelioma (C30.0) |
| 9530/0 | Meningioma, NOS |
| 9530/1 | Meningiomatosis, NOS |
| 9530/3 | Meningioma, malignant |
| 9531/0 | Meningothelial meningioma |
| 9532/0 | Fibrous meningioma |
| 9533/0 | Psammomatous meningioma |
| 9534/0 | Angiomatous meningioma |
| 9535/0 | Hemangioblastic meningioma [obs] |
| 9537/0 | Transitional meningioma |
| 9538/1 | Clear cell meningioma |
| 9538/3 | Papillary meningioma |
| 9539/1 | Atypical meningioma |
| 9539/3 | Meningeal sarcomatosis |
| 9590/3 | Malignant lymphoma, NOS |
| 9591/3 | Malignant lymphoma, non-Hodgkin, NOS |
| 9596/3 | Composite Hodgkin and non-Hodgkin lymphoma |
| 9650/3 | Hodgkin lymphoma, NOS |
| 9651/3 | Hodgkin lymphoma, lymphocyte-rich |
| 9652/3 | Hodgkin lymphoma, mixed cellularity, NOS |
| 9653/3 | Hodgkin lymphoma, lymphocyte depletion, NOS |
| 9654/3 | Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis |
| 9655/3 | Hodgkin lymphoma, lymphocyte depletion, reticular |
| 9659/3 | Hodgkin lymphoma, nodular lymphocyte predominance |
| 9661/3 | Hodgkin granuloma [obs] |
| 9662/3 | Hodgkin sarcoma [obs] |
| 9663/3 | Hodgkin lymphoma, nodular sclerosis, NOS |
| 9664/3 | Hodgkin lymphoma, nodular sclerosis, cellular phase |
| 9665/3 | Hodgkin lymphoma, nodular sclerosis, grade 1 |
| 9667/3 | Hodgkin lymphoma, nodular sclerosis, grade 2 |
| 9670/3 | Malignant lymphoma, small B lymphocytic, NOS (see also M-9823/3) |
| 9671/3 | Malignant lymphoma, lymphoplasmacytic (see also M-9761/3) |
| 9673/3 | Mantle cell lymphoma |
| 9675/3 | Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690/3) |
| 9678/3 | Primary effusion lymphoma |
| 9679/3 | Mediastinal large B-cell lymphoma (C38.3) |
| 9680/3 | Malignant lymphoma, large B-cell, diffuse, NOS |
| 9684/3 | Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS |
| 9687/3 | Burkitt lymphoma, NOS (see also M-9826/3) |
| 9689/3 | Splenic marginal zone B-cell lymphoma (C42.2) |
| 9690/3 | Follicular lymphoma, NOS (see also M-9675/3) |
| 9691/3 | Follicular lymphoma, grade 2 |
| 9695/3 | Follicular lymphoma, grade 1 |
| 9698/3 | Follicular lymphoma, grade 3 |
| 9699/3 | Marginal zone B-cell lymphoma, NOS |
| 9700/3 | Mycosis fungoides (C44._) |
| 9701/3 | Sezary syndrome |
| 9702/3 | Mature T-cell lymphoma, NOS |
| 9705/3 | Angioimmunoblastic T-cell lymphoma |
| 9708/3 | Subcutaneous panniculitis-like T-cell lymphoma |
| 9709/3 | Cutaneous T-cell lymphoma, NOS (C44._) |
| 9714/3 | Anaplastic large cell lymphoma, T cell and Null cell type |
| 9716/3 | Hepatosplenic ?? (gamma-delta) cell lymphoma |
| 9717/3 | Intestinal T-cell lymphoma |
| 9718/3 | Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) |
| 9719/3 | NK/T-cell lymphoma, nasal and nasal-type |
| 9727/3 | Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) |
| 9728/3 | Precursor B-cell lymphoblastic lymphoma (see also M-9836/3) |
| 9729/3 | Precursor T-cell lymphoblastic lymphoma (see also M-9837/3) |
| 9731/3 | Plasmacytoma, NOS |
| 9732/3 | Multiple myeloma (C42.1) |
| 9733/3 | Plasma cell leukemia (C42.1) |
| 9734/3 | Plasmacytoma, extramedullary (not occurring in bone) |
| 9740/1 | Mastocytoma, NOS |
| 9740/3 | Mast cell sarcoma |
| 9741/3 | Malignant mastocytosis |
| 9742/3 | Mast cell leukemia (C42.1) |
| 9750/3 | Malignant histiocytosis |
| 9751/1 | Langerhans cell histiocytosis, NOS |
| 9752/1 | Langerhans cell histiocytosis, unifocal |
| 9753/1 | Langerhans cell histiocytosis, multifocal |
| 9754/3 | Langerhans cell histiocytosis, disseminated |
| 9755/3 | Histiocytic sarcoma |
| 9756/3 | Langerhans cell sarcoma |
| 9757/3 | Interdigitating dendritic cell sarcoma |
| 9758/3 | Follicular dendritic cell sarcoma |
| 9760/3 | Immunoproliferative disease, NOS |
| 9761/3 | Waldenstrom macroglobulinemia (C42.0) (see also M-9671/3) |
| 9762/3 | Heavy chain disease, NOS |
| 9764/3 | Immunoproliferative small intestinal disease (C17._) |
| 9765/1 | Monoclonal gammopathy of undetermined significance |
| 9766/1 | Angiocentric immunoproliferative lesion |
| 9767/1 | Angioimmunoblastic lymphadenopathy |
| 9768/1 | T-gamma lymphoproliferative disease |
| 9769/1 | Immunoglobulin deposition disease |
| 9800/3 | Leukemia, NOS |
| 9801/3 | Acute leukemia, NOS |
| 9805/3 | Acute biphenotypic leukemia |
| 9820/3 | Lymphoid leukemia, NOS |
| 9823/3 | B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) |
| 9826/3 | Burkitt cell leukemia (see also M-9687/3) |
| 9827/3 | Adult T-cell leukemia/lymphoma (HTLV-1 positive) Includes all variants |
| 9831/1 | T-cell large granular lymphocytic leukemia |
| 9832/3 | Prolymphocytic leukemia, NOS |
| 9833/3 | Prolymphocytic leukemia, B-cell type |
| 9834/3 | Prolymphocytic leukemia, T-cell type |
| 9835/3 | Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3) |
| 9836/3 | Precursor B-cell lymphoblastic leukemia (see also M-9728/3) |
| 9837/3 | Precursor T-cell lymphoblastic leukemia (see also M-9729/3) |
| 9840/3 | Acute myeloid leukemia, M6 type |
| 9860/3 | Myeloid leukemia, NOS |
| 9861/3 | Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3) |
| 9863/3 | Chronic myeloid leukemia, NOS |
| 9866/3 | Acute promyelocytic leukemia, t(15;17)(q22;q11-12) |
| 9867/3 | Acute myelomonocytic leukemia |
| 9870/3 | Acute basophilic leukemia |
| 9871/3 | Acute myeloid leukemia with abnormal marrow eosinophils Includes all variants |
| 9872/3 | Acute myeloid leukemia, minimal differentiation |
| 9873/3 | Acute myeloid leukemia without maturation |
| 9874/3 | Acute myeloid leukemia with maturation |
| 9875/3 | Chronic myelogenous leukemia, BCR/ABL positive |
| 9876/3 | Atypical chronic myeloid leukemia, BCR/ABL negative |
| 9891/3 | Acute monocytic leukemia |
| 9895/3 | Acute myeloid leukemia with multilineage dysplasia |
| 9896/3 | Acute myeloid leukemia, t(8;21)(q22;q22) |
| 9897/3 | Acute myeloid leukemia, 11q23 abnormalities |
| 9910/3 | Acute megakaryoblastic leukemia |
| 9920/3 | Therapy-related acute myeloid leukemia, NOS |
| 9930/3 | Myeloid sarcoma (see also M-9861/3) |
| 9931/3 | Acute panmyelosis with myelofibrosis (C42.1) |
| 9940/3 | Hairy cell leukemia (C42.1) |
| 9945/3 | Chronic myelomonocytic leukemia, NOS |
| 9946/3 | Juvenile myelomonocytic leukemia |
| 9948/3 | Aggressive NK-cell leukemia |
| 9950/3 | Polycythemia vera |
| 9960/3 | Chronic myeloproliferative disease, NOS |
| 9961/3 | Myelosclerosis with myeloid metaplasia |
| 9962/3 | Essential thrombocythemia |
| 9963/3 | Chronic neutrophilic leukemia |
| 9964/3 | Hypereosinophilic syndrome |
| 9970/1 | Lymphoproliferative disorder, NOS |
| 9975/1 | Myeloproliferative disease, NOS |
| 9980/3 | Refractory anemia |
| 9982/3 | Refractory anemia with sideroblasts |
| 9983/3 | Refractory anemia with excess blasts |
| 9984/3 | Refractory anemia with excess blasts in transformation [obs] |
| 9985/3 | Refractory cytopenia with multilineage dysplasia |
| 9986/3 | Myelodysplastic syndrome with 5q deletion (5q-) syndrome |
| 9987/3 | Therapy-related myelodysplastic syndrome, NOS |
| 9989/3 | Myelodysplastic syndrome, NOS |